ECM
DGX icon

ETrade Capital Management’s Quest Diagnostics DGX Stock Holding History

ETrade Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.52M Buy
13,291
+212
+2% +$25K 0.03% 271
2020
Q2 		$1.49M Sell
13,079
-235
-2% -$24.9K 0.03% 257
2020
Q1 		$1.07M Sell
13,314
-4,630
-26% -$479K 0.03% 279
2019
Q4 		$1.92M Sell
17,944
-2,589
-13% -$270K 0.04% 218
2019
Q3 		$2.2M Sell
20,533
-26,671
-57% -$2.74M 0.06% 203
2019
Q2 		$4.81M Buy
47,204
+4,318
+10% +$415K 0.13% 84
2019
Q1 		$3.86M Buy
42,886
+11,800
+38% +$1.02M 0.11% 107
2018
Q4 		$2.59M Sell
31,086
-770
-2% -$72.2K 0.08% 134
2018
Q3 		$3.44M Buy
31,856
+5,806
+22% +$637K 0.1% 115
2018
Q2 		$2.86M Buy
26,050
+42
+0.2% +$4.38K 0.09% 133
2018
Q1 		$2.61M Sell
26,008
-1,297
-5% -$133K 0.08% 133
2017
Q4 		$2.69M Buy
27,305
+5,185
+23% +$492K 0.09% 132
2017
Q3 		$2.07M Sell
22,120
-2,358
-10% -$250K 0.07% 162
2017
Q2 		$2.72M Sell
24,478
-1,676
-6% -$177K 0.1% 106
2017
Q1 		$2.57M Sell
26,154
-2,506
-9% -$239K 0.11% 111
2016
Q4 		$2.63M Sell
28,660
-3,916
-12% -$338K 0.12% 102
2016
Q3 		$2.76M Buy
32,576
+499
+2% +$41.9K 0.13% 87
2016
Q2 		$2.61M Sell
32,077
-630
-2% -$48K 0.14% 82
2016
Q1 		$2.34M Sell
32,707
-1,252
-4% -$84K 0.13% 84
2015
Q4 		$2.42M Buy
33,959
+470
+1% +$31.6K 0.14% 78
2015
Q3 		$2.06M Buy
33,489
+1,256
+4% +$87.8K 0.13% 99
2015
Q2 		$2.34M Sell
32,233
-420
-1% -$31K 0.14% 87
2015
Q1 		$2.51M Buy
32,653
+2,644
+9% +$189K 0.15% 83
2014
Q4 		$2.01M Buy
30,009
+1,522
+5% +$96K 0.12% 111
2014
Q3 		$1.73M Buy
28,487
+79
+0.3% +$4.87K 0.11% 133
2014
Q2 		$1.67M Buy
28,408
+3,231
+13% +$189K 0.11% 141
2014
Q1 		$1.46M Buy
25,177
+8,044
+47% +$431K 0.1% 150
2013
Q4 		$917K Buy
17,133
+5,059
+42% +$300K 0.07% 205
2013
Q3 		$746K Buy
12,074
+3,057
+34% +$183K 0.07% 199
2013
Q2 		$547K Buy
+9,017
New +$537K 0.06% 209

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ETrade Capital Management's DGX Position: Q3 2020 in Review

ETrade Capital Management increased its Quest Diagnostics (DGX) stake by 1.6% in Q3 2020, buying an estimated $25K and bringing the position to 13,291 shares worth $1.52M. The position accounts for 0.03% of the portfolio, ranked #271.

ETrade Capital Management first reported a position in DGX in Q2 2013 and has held it in 30 quarters since. The position peaked at $4.81M in Q2 2019. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • ETrade Capital Management held 13,291 shares of Quest Diagnostics worth $1.52M as of Q3 2020.
  • ETrade Capital Management bought 212 Quest Diagnostics shares in Q3 2020, an estimated $25K.
  • Quest Diagnostics made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #271 holding.
  • ETrade Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 30 quarters since.
  • ETrade Capital Management's Quest Diagnostics position peaked at $4.81M in Q2 2019.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.